SCHEMBL8308532

SCHEMBL8308532

CCOc1cc(/C=C2\SC(=S)NC2=O)ccc1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 8/20 1.00
PDE3A Q14432 6/20 1.00
DYRK1A Q13627 3/20 1.00
MEN1 O00255 3/20 0.91
KMT2A Q03164 3/20 0.91
ALDH1A1 P00352 2/20 0.91
MAPT P10636 2/20 0.91
LMNA P02545 1/20 0.91
NPSR1 Q6W5P4 1/20 0.91
PIM1 P11309 2/20 0.75
PIM3 Q86V86 2/20 0.75
PIM2 Q9P1W9 2/20 0.75
DYRK2 Q92630 1/20 0.75
IGF1R P08069 1/20 0.72
CISD1 Q9NZ45 3/20 0.69
MAOA P21397 1/20 0.69
MAOB P27338 1/20 0.69
CDC7 O00311 1/20 0.69
PLK4 O00444 1/20 0.69
DAPK3 O43293 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8308535 1.00 PDE4B (1.00) PDE4BPDE3ADYRK1AMEN1KMT2A
SCHEMBL8307072 0.95 PDE4B (1.00) PDE4BPDE3ADYRK1AMEN1KMT2A
SCHEMBL8307071 0.95 PDE4B (1.00) PDE4BPDE3ADYRK1AMEN1KMT2A
SCHEMBL8311581 0.94 PDE4B (1.00) PDE4BPDE3ADYRK1AMEN1KMT2A
SCHEMBL8311580 0.94 PDE4B (1.00) PDE4BPDE3ADYRK1AMEN1KMT2A
SCHEMBL8171882 0.90 PDE4B (1.00) PDE4BPDE3ADYRK1AMEN1KMT2A
SCHEMBL15421279 0.90 PDE4B (1.00) PDE4BPDE3ADYRK1AMEN1KMT2A
SCHEMBL8171885 0.90 PDE4B (1.00) PDE4BPDE3ADYRK1AMEN1KMT2A
SCHEMBL8310975 0.88 PDE4B (0.89) PDE4BPDE3ADYRK1AMEN1KMT2A
SCHEMBL8306525 0.88 PDE4B (0.89) PDE4BPDE3ADYRK1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915090-A1 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1999-05-12 EP disclosed
US-5716975-A NONTOXIC RHODANINE DERIVATIVES; ANTIDIABETIC AGENTS, CATHEPSIN D INHIBITORS, B-AMYLOID PROTEIN REDUCTION ELI LILLY AND COMPANY (US) 1998-02-10 US disclosed
US-5661168-A ADMINISTERING RHODANINE DERIVATIVES TO CONTROL DIABETES ELI LILLY AND COMPANY (US) 1997-08-26 US disclosed
US-5523314-A RHODANINE DERIVATIVES ELI LILLY AND COMPANY (US) 1996-06-04 US disclosed
EP-0587377-A2 Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1994-03-16 EP disclosed